Novavax
NVAX
#5514
Rank
NZ$2.31 B
Marketcap
NZ$14.27
Share price
-5.54%
Change (1 day)
-6.07%
Change (1 year)

Market capitalization of Novavax (NVAX)

Market cap: NZ$2.31 Billion

As of January 2026 Novavax has a market cap of NZ$2.31 Billion. This makes Novavax the world's 5514th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Novavax from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$2.31 B20.97%
2025NZ$1.91 B-18.51%
2024NZ$2.35 B160.83%
2023NZ$0.90 B-34.49%
2022NZ$1.37 B-91.31%
2021NZ$15.83 B60.97%
2020NZ$9.83 B5045.81%
2019NZ$0.19 B-81.87%
2018NZ$1.05 B60.9%
2017NZ$0.65 B32.84%
2016NZ$0.49 B-85.09%
2015NZ$3.30 B83.09%
2014NZ$1.80 B39.04%
2013NZ$1.30 B282.48%
2012NZ$0.33 B83.12%
2011NZ$0.18 B-46.93%
2010NZ$0.34 B-4.75%
2009NZ$0.36 B63%
2008NZ$0.22 B-16.35%
2007NZ$0.26 B-25.11%
2006NZ$0.35 B16.64%
2005NZ$0.30 B70.61%
2004NZ$0.18 B-43.61%
2003NZ$0.32 B158.3%
2002NZ$0.12 B-84.32%
2001NZ$0.79 B86.56%
2000NZ$0.42 B159.71%
1999NZ$0.16 B265.94%
1998NZ$44.61 M-56.9%
1997NZ$0.10 B99.5%
1996NZ$51.87 M

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of Novavax was reported to be:

NZ$2.31 Billion
by Nasdaq info icon info icon
NZ$2.31 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Agenus
AGEN
NZ$0.27 B-88.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
NZ$4.16 B 79.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
NZ$1.16 B-49.73%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ$2.48 B 7.36%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$520.32 B 22,344.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$253.34 B 10,828.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$488.51 B 20,972.78%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
NZ$43.2 M-98.14%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
NZ$178.80 B 7,612.94%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
NZ$3.04 B 31.51%๐Ÿ‡บ๐Ÿ‡ธ USA